Physiological functions and underlying mechanisms of Fibroblast Growth Factor (FGF) family members: Recent findings and implications for their pharmacological application

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 7, 2014, Pages 1081-1089

  Imamura, Toru ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Co receptor; Fibroblast growth factor (FGF); Glycosaminoglycan; Hair growth cycle; Radioprotection; Stem cell

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR C; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOSAMINOGLYCAN; KERATINOCYTE GROWTH FACTOR; KLOTHO PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; HYBRID PROTEIN; KLB PROTEIN, HUMAN; MEMBRANE PROTEIN; RADIOPROTECTIVE AGENT;

DRUG MECHANISM; HAIR GROWTH; HUMAN; IRRADIATION; MUCOSA INFLAMMATION; NONHUMAN; ORAL MUCOSITIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIATION PROTECTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN ULCER; STEM CELL; ANIMAL; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAIR FOLLICLE; METABOLISM; PHYSIOLOGY; RADIATION INJURIES, EXPERIMENTAL;

ANIMALS; CELL LINE; FIBROBLAST GROWTH FACTORS; HAIR FOLLICLE; HUMANS; MEMBRANE PROTEINS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 84904648779     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00265     Document Type: Review

References (60)

1. Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet., 20, 563-569 (2004).
2. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T. βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol., 22, 1006-1014 (2008).
3. Nakamura M, Uehara Y, Asada M, Honda E, Nagai N, Kimata K, Suzuki M, Imamura T. Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho. J. Biol. Chem., 286, 26418-26423 (2011).
4. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta, 1492, 203-206 (2000).
5. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J. Clin. Invest., 115, 1627-1635 (2005).
6. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab., 5, 415-425 (2007).
7. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab., 5, 426-437 (2007).
8. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M. Regulation of fibroblast growth factor-23 signaling by Klotho. J. Biol. Chem., 281, 6120-6123 (2006).
9. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature, 444, 770-774 (2006).
10. Ito S, Kinoshita S, Shiraishi N, Nakagawa S, Sekine S, Fujimori T, Nabeshima YI. Molecular cloning and expression analyses of mouse betaKlotho, which encodes a novel Klotho family protein. Mech. Dev., 98, 115-119 (2000).
11. Asada M, Shinomiya M, Suzuki M, Honda E, Sugimoto R, Ikekita M, Imamura T. Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim. Biophys. Acta, 1790, 40-48 (2009).
12. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab., 2, 217-225 (2005).
13. Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, Stewart TA. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology, 143, 1741-1747 (2002).
14. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, Stewart TA. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology, 145, 2594-2603 (2004).
15. Strack AM, Myers RW. Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)? Endocrinology, 145, 2591-2593 (2004).
16. Kharitonenkov A. FGFs and metabolism. Curr. Opin. Pharmacol., 9, 805-810 (2009).
17. Wu X, Lemon B, Li X, Gupte J, Weiszmann, Stevens J, Hawkins N, Shen W, Lindberg R, Chen JL, Tian H, Li Y. C-Terminal tail of FGF19 determines its specificity toward Klotho co-receptors. J. Biol. Chem., 283, 33304-33309 (2008).
18. Wu X, Ge H, Lemon B, Weiszmann J, Gupte J, Hawkins N, Li X, Tang J, Lindberg R, Li Y. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc. Natl. Acad. Sci. U.S.A., 106, 14379-14384 (2009).
19. Wu X, Ge H, Lemon B, Vonderfecht S, Baribault H, Weiszmann J, Gupte J, Gardner J, Lindberg R, Wang Z, Li Y. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc. Natl. Acad. Sci. U.S.A., 107, 14158-14163 (2010).
20. Lundåsen T, Gälman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med., 260, 530-536 (2006).
21. Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H, Haluzík M. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab., 93, 3627-3632 (2008).
22. Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology, 49, 1228-1235 (2009).
23. Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M. Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol., 27, 3417-3428 (2007).
24. Desnoyers LR, Pai R, Ferrando RE, Hötzel K, Le T, Ross J, Carano R, D'Souza A, Qing J, Mohtashemi I, Ashkenazi A, French DM. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene, 27, 85-97 (2008).
25. Kawano M, Komi-Kuramochi A, Asada M, Suzuki M, Oki J, Jiang J, Imamura T. Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. J. Invest. Dermatol., 124, 877-885 (2005).
26. Kimura-Ueki M, Oda Y, Oki J, Komi-Kuramochi A, Honda E, Asada M, Suzuki M, Imamura T. Hair cycle resting phase is regulated by cyclic epithelial FGF18 signaling. J. Invest. Dermatol., 132, 1338-1345 (2012).
27. Suzuki S, Ota Y, Ozawa K, Imamura T. Dual-mode regulation of hair growth cycle by two Fgf-5 gene products. J. Invest. Dermatol., 114, 456-463 (2000).
28. Hébert JM, Rosenquist T, Götz J, Martin GR. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell, 78, 1017-1025 (1994).
29. Ota Y, Saitoh Y, Suzuki S, Ozawa K, Kawano M, Imamura T. Fibroblast growth factor 5 inhibits hair growth by blocking dermal papilla cell activation. Biochem. Biophys. Res. Commun., 290, 169-176 (2002).
30. Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, Oki J, Imamura T. Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J. Endocrinol., 186, 273-289 (2005).
31. Müller-Röver S, Handjiski B, van der Veen C, Eichmüller S, Foitzik K, McKay IA, Stenn KS, Paus R. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J. Invest. Dermatol., 117, 3-15 (2001).
32. Liu Y, Lyle S, Yang Z, Cotsarelis G. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J. Invest. Dermatol., 121, 963-968 (2003).
33. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem., 281, 15694-15700 (2006).
34. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev., 16, 870-879 (2002).
35. Greco V, Chen T, Rendl M, Schober M, Pasolli HA, Stokes N, Dela Cruz-Racelis J, Fuchs E. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell, 4, 155-169 (2009).
36. Plikus MV, Mayer JA, de la Cruz D, Baker RE, Maini PK, Maxson R, Chuong CM. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature, 451, 340-344 (2008).
37. Rendl M, Polak L, Fuchs E. BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev., 22, 543-557 (2008).
38. Millar SE. Molecular mechanisms regulating hair follicle development. J. Invest. Dermatol., 118, 216-225 (2002).
39. Yuhki M, Yamada M, Kawano M, Iwasato T, Itohara S, Yoshida H, Ogawa M, Mishina Y. BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice. Development, 131, 1825-1833 (2004).
40. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J. Cell. Biochem., 97, 33-44 (2006).
41. Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev., 16, 1446-1465 (2002).
42. Motomura K, Hagiwara A, Komi-Kuramochi A, Hanyu Y, Honda E, Suzuki M, Kimura M, Oki J, Asada M, Sakaguchi N, Nakayama F, Akashi M, Imamura T. An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection. Biochim. Biophys. Acta, 780, 1432-1440 (2008).
43. Nakayama F, Hagiwara A, Umeda S, Asada M, Gotoh M, Oki J, Suzuki M, Imamura T, Akashi M. Post treatment with an FGF chimeric growth factor enhances epithelial cell proliferation to improve recovery from radiation-induced intestinal damage. Int. J. Radiat. Oncol. Biol. Phys., 78, 860-867 (2010).
44. Imamura T, Friedman SA, Gamble S, Tokita Y, Opalenik SR, Thompson JA, Maciag T. Identification of the domain within fibroblast growth factor-1 responsible for heparin-dependence. Biochim. Biophys. Acta, 1266, 124-130 (1995).
45. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem., 271, 15292-15297 (1996).
46. Zakrzewska M, Krowarsch D, Wiedlocha A, Olsnes S, Otlewski J. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action. J. Mol. Biol., 352, 860-875 (2005).
47. Zakrzewska M, Krowarsch D, Wiedlocha A, Otlewski J. Design of fully active FGF-1 variants with increased stability. Protein Eng. Des. Sel., 17, 603-611 (2004).
48. Copeland RA, Ji H, Halfpenny AJ, Williams RW, Thompson KC, Herber WK, Thomas KA, Bruner MW, Ryan JA, Marquis-Omer D, Sanyal G, Sitrin RD, Yamazaki S, Middaugh CR. The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch. Biochem. Biophys., 289, 53-61 (1991).
49. Fan H, Vitharana SN, Chen T, O'Keefe D, Middaugh CR. Effects of pH and poluanions on the thermal stability of fibroblast growth factor 20. Mol. Pharm., 4, 232-240 (2007).
50. Blaber SI, Culajay JF, Khurana A, Blaber M. Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride. Biophys. J., 77, 470-477 (1999).
51. Meier K, Nanney LB. Emerging new drugs for wound repair. Expert Opin. Emerg. Drugs, 11, 23-37 (2006).
52. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams LT. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science, 266, 819-822 (1994).
53. Withers HR, Elkind MM. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 17, 261-267 (1970).
54. Okunieff P, Mester M, Wang J, Maddox T, Gong X, Tang D, Coffee M, Ding I. In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat. Res., 150, 204-211 (1998).
55. Wu N, Sun H, Liu W, Xu H, Lu W. The effects of Ligustrazine on the expression of bFGF and bFGFR in bone marrow in radiation injured mice. J. Huazhong Univ. Sci. Technolog. Med. Sci., 23, 348-351 (2003).
56. Potten CS, O'Shea JA, Farrell CL, Rex K, Booth C. The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine. Cell Growth Differ., 12, 265-275 (2001).
57. Okunieff P, Li M, Liu W, Sun J, Fenton B, Zhang L, Ding I. Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. Am. J. Clin. Oncol., 24, 491-495 (2001).
58. Maclachlan T, Narayanan B, Gerlach VL, Smithson G, Gerwien RW, Folkerts O, Fey EG, Watkins B, Seed T, Alvarez E. Human fibroblast growth factor 20 (FGF-20; CG53135-05): a novel cyto-protectant with radioprotective potential. Int. J. Radiat. Biol., 81, 567-579 (2005).
59. Nakayama F, Hagiwara A, Kimura M, Akashi M, Imamura T. Evaluation of radiation-induced hair follicle apoptosis in mice and the preventive effects of fibroblast growth factor-1. Exp. Dermatol., 18, 889-892 (2009).
60. Hagiwara A, Nakayama F, Motomura K, Asada M, Suzuki M, Imamura T, Akashi M. Comparison of expression profiles of several fibroblast growth factor receptors in the mouse jejunum: Suggestive evidence for a differential radioprotective effect among major FGF family members and the potency of FGF1. Radiat. Res., 172, 58-65 (2009).